Tag

Truvada

All articles tagged with #truvada

health2 years ago•6 min saved

Gilead emerges victorious in HIV drug patent lawsuit against US government.

A federal jury in Delaware has ruled that the US government does not have an ownership claim to lucrative drugs to prevent HIV that are sold by Gilead Sciences. The verdict marked a defeat for the government and activists who have pushed it to more aggressively assert its financial and legal rights to medicines developed with the help of public funding. The legal dispute centered on who devised the idea of using a Gilead medication for people at high risk of contracting HIV, which causes AIDS.

via The New York Times|

#gilead-sciences #government-lawsuit #health

business2 years ago•2 min saved

Gilead Sciences emerges victorious in HIV drug patent lawsuit against US government.

Gilead Sciences has won a lawsuit filed by the US government over HIV drug patents. The government had claimed that Gilead failed to compensate the US Centers for Disease Control and Prevention (CDC) for discovering that its drug Truvada, which was first approved to treat HIV, could also help prevent infection by the virus. However, a federal jury found that Gilead did not infringe US patents with its HIV-prevention regimens using Truvada and Descovy, and that the government's patents were invalid and not infringed.

via Reuters|

#business #descovy #gilead-sciences

health2 years ago•1 min saved

Jury rules in favor of Gilead Sciences in HIV prevention treatment patent case.

A Delaware jury has ruled that Gilead Sciences did not violate patents held by the Centers for Disease and Prevention on an HIV prevention drug. The US government had sued Gilead in 2019, alleging that the company was profiting off CDC patents through the sales of Truvada and Descovy. The jury found that the government's patent claims on an HIV prevention regimen called pre-exposure prophylaxis, or PrEP, were not valid after a multiday trial in federal court.

via CNBC|

#cdc #descovy #gilead-sciences

healthcare2 years ago•2 min saved

Gilead faces U.S. government in HIV prevention patent trial.

Gilead Sciences is facing allegations from the US government that the company violated patents for a crucial HIV prevention drug regimen, known as pre-exposure prophylaxis (PrEP), by reaping billions of dollars in PrEP sales without paying royalties to the Centers for Disease Control and Prevention (CDC). The trial in Delaware federal district court is expected to last six days. Gilead rejects the CDC's claims and argues that it is not obligated to apply for a license with the CDC or pay the agency any royalties.

via CNBC|

#gilead-sciences #healthcare #hiv-prevention